OptimalHealthNutrition.com

 

 
 

Update: Please see the new website at HealGrowThriveMedicine.com

 



Shopping cart  Shopping cart
0 Product(s) in cart
Total $0.00
» Checkout

Valid XHTML 1.0 Transitional

© Copyright 2008
Shopping cart software by Ecommerce Templates

 

NFKB modulation 

Research News: Pharmaceutical companies are currently scrambling to develop clinically useful synthetic inhibitors of NF-kappaB. These companies will eventually be successful in this endeavor, and we can also confidently predict that the pharmaceutical version of NF-kappaB suppression will arrive with a plethora of adverse effects, most likely because of the potency and specificity of the drug. NF-kappaB plays an important role in a wide range of normal, healthy physiologic processes, including the immune response to infectious diseases. We should therefore seek to modulate its function rather than sophomorically suppress its function. Fortunately, we can do this with several natural interventions, not the least of which are vitamin D[1],[2], curcumin[3] (requires piperine for absorption[4]), lipoic acid[5], green tea[6], rosemary[7], grape seed extract[8], propolis[9], zinc[10], high-dose selenium[11], indole-3-carbinol[12],[13], N-acetyl-L-cysteine[14], and resveratrol.[15],[16] Other nutrients such as isohumulones from Humulus lupulus[17] and fatty acids inhibit NF-kappaB indirectly via activation of peroxisome proliferator-activated receptors alpha (PPAR-ά) and gamma (PPAR-γ). GLA activates PPAR-gamma and thereby inhibits NF-kappaB[18], while (oxidized) EPA activates PPAR-alpha and thus inhibits NF-kappaB[19]; these latter findings reflect a quantum leap in our understanding of the mechanisms of diet-induced anti-inflammation (i.e., anti-inflammatory nutrigenomics, or anti-inflammatory immunonutrigenomics) since they show that food constituents modify human physiology and phenotype at the genetic/pre-transcriptional level and not only at the metabolic/post-transcriptional level as was previously thought.[20]





--------------------------------------------------------------------------------

[1] “1Alpha,25-dihydroxyvitamin D3 (1,25-(OH)2-D3), the active metabolite of vitamin D, can inhibit NF-kappaB activity in human MRC-5 fibroblasts, targeting DNA binding of NF-kappaB but not translocation of its subunits p50 and p65.” Harant H, Wolff B, Lindley IJ. 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Lett. 1998 Oct 9;436(3):329-34

[2] “Thus, 1,25(OH)2D3 may negatively regulate IL-12 production by downregulation of NF-kB activation and binding to the p40-kB sequence.” D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest. 1998 Jan 1;101(1):252-62

[3] “Curcumin, EGCG and resveratrol have been shown to suppress activation of NF-kappa B.” Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001 Sep 1;480-481:243-68

[4] Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May;64(4):353-6

[5] “ALA reduced the TNF-alpha-stimulated ICAM-1 expression in a dose-dependent manner, to levels observed in unstimulated cells. Alpha-lipoic acid also reduced NF-kappaB activity in these cells in a dose-dependent manner.” Lee HA, Hughes DA.Alpha-lipoic acid modulates NF-kappaB activity in human monocytic cells by direct interaction with DNA. Exp Gerontol. 2002 Jan-Mar;37(2-3):401-10

[6] “In conclusion, EGCG is an effective inhibitor of IKK activity. This may explain, at least in part, some of the reported anti-inflammatory and anticancer effects of green tea.” Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol. 2001 Sep;60(3):528-33

[7] “These results suggest that carnosol suppresses the NO production and iNOS gene expression by inhibiting NF-kappaB activation, and provide possible mechanisms for its anti-inflammatory and chemopreventive action.” Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis. 2002 Jun;23(6):983-91

[8] “Constitutive and TNFalpha-induced NF-kappaB DNA binding activity was inhibited by GSE at doses > or =50 microg/ml and treatments for > or =12 h.” Dhanalakshmi S, Agarwal R, Agarwal C. Inhibition of NF-kappaB pathway in grape seed extract-induced apoptotic death of human prostate carcinoma DU145 cells. Int J Oncol. 2003 Sep;23(3):721-7

[9] “Caffeic acid phenethyl ester (CAPE) is an anti-inflammatory component of propolis (honeybee resin). CAPE is reportedly a specific inhibitor of nuclear factor-kappaB (NF-kappaB).” Fitzpatrick LR, Wang J, Le T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J Pharmacol Exp Ther. 2001 Dec;299(3):915-20

[10] "Our results suggest that zinc supplementation may lead to downregulation of the inflammatory cytokines through upregulation of the negative feedback loop A20 to inhibit induced NF-kappaB activation." Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH. Antioxidant effect of zinc in humans. Free Radic Biol Med. 2004 Oct 15;37(8):1182-90

[11] Note that the patients in this study received a very high dose of selenium: 960 micrograms per day. This is at the top—and some would say over the top—of the safe and reasonable dose for long-term supplementation. In this case, th study lasted for three months. "In patients receiving selenium supplementation, selenium NF-kappaB activity was significantly reduced, reaching the same level as the nondiabetic control group. CONCLUSION: In type 2 diabetic patients, activation of NF-kappaB measured in peripheral blood monocytes can be reduced by selenium supplementation, confirming its importance in the prevention of cardiovascular diseases." Faure P, Ramon O, Favier A, Halimi S. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest. 2004 Jul;34(7):475-81

[12] Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-{kappa}B and I{kappa}B{alpha} kinase activation causing inhibition of expression of NF-{kappa}B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood. 2005 Apr 5; [Epub ahead of print]

[13] "Overall, our results indicated that indole-3-carbinol inhibits NF-kappaB and NF-kappaB-regulated gene expression and that this mechanism may provide the molecular basis for its ability to suppress tumorigenesis." Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood. 2005 Jul 15;106(2):641-9. Epub 2005 Apr 5.

[14] "CONCLUSIONS: Administration of N-acetylcysteine results in decreased nuclear factor-kappa B activation in patients with sepsis, associated with decreases in interleukin-8 but not interleukin-6 or soluble intercellular adhesion molecule-1. These pilot data suggest that antioxidant therapy with N-acetylcysteine may be useful in blunting the inflammatory response to sepsis." Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003 Nov;31(11):2574-8

[15] “Resveratrol's anticarcinogenic, anti-inflammatory, and growth-modulatory effects may thus be partially ascribed to the inhibition of activation of NF-kappaB and AP-1 and the associated kinases.” Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol. 2000 Jun 15;164(12):6509-19

[16] “Both resveratrol and quercetin inhibited NF-kappaB-, AP-1- and CREB-dependent transcription to a greater extent than the glucocorticosteroid, dexamethasone.” Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, Barnes PJ.Anti-inflammatory Effects of Resveratrol in Lung Epithelial Cells: Molecular Mechanisms. Am J Physiol Lung Cell Mol Physiol. 2004 Jun 4 [Epub ahead of print]

[17] Yajima H, Ikeshima E, Shiraki M, Kanaya T, Fujiwara D, Odai H, Tsuboyama-Kasaoka N, Ezaki O, Oikawa S, Kondo K. Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance. J Biol Chem. 2004 Aug 6;279(32):33456-62. Epub 2004 Jun 3. http://www.jbc.org/cgi/content/full/279/32/33456

[18] “Thus, PPAR gamma serves as the receptor for GLA in the regulation of gene expression in breast cancer cells. “ Jiang WG, Redfern A, Bryce RP, Mansel RE. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells. Prostaglandins Leukot Essent Fatty Acids. 2000 Feb;62(2):119-27

[19] "...EPA requires PPARalpha for its inhibitory effects on NF-kappaB." Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1621-7. Epub 2004 Jul 1. http://atvb.ahajournals.org/cgi/content/full/24/9/1621

[20] “Indeed, the previous view that nutrients only interact with human physiology at the metabolic/post-transcriptional level must be updated in light of current research showing that nutrients can, in fact, modify human physiology and phenotype at the genetic/pre-transcriptional level.” Vasquez A. Reducing pain and inflammation naturally - part 4: nutritional and botanical inhibition of NF-kappaB, the major intracellular amplifier of the inflammatory cascade. A practical clinical strategy exemplifying anti-inflammatory nutrigenomics. Nutritional Perspectives, July 2005:5-12. www.OptimalHealthResearch.com/part4

 
Dr Vasquez's Comments: This is an excerpt from my textbook "Chiropractic and Naturopathic Mastery of Common Clinical Disorders" which is available from OptimalHealthResearch.com (website with clinical information designed for doctors) and also from OptimalHealthNutrition.com in our selection of books.

DOCTORS: See Optimal Health Research for textbooks and clinical protocols!

 

 

 

 

 

 

See our new site at AntiCancer Cookbook.com -- coming soon!

 

       

All Products | Browse Items | Search Items | Secure Ordering | Customer Entrance | eNews, Audio MP3 Videos & PodCasts | About | Site Contents | Community Links | Consult Dr Vasquez

OptimalHealthNutrition.com provides information for patients and the general public, while OptimalHealthResearch.com provides information for medical/chiropractic/osteopathic/naturopathic students and doctors. These sites are owned by Integrative and Biological Medicine Research and Consulting LLC (IBMRC).  Copyright 2009 by IBMRC and/or Dr Alex Vasquez.  All rights reserved.  Use of this site implies agreement with our Terms & Agreements.  Caution: Bee products may cause allergic reactions in some people. Due to honey content, not recommended for children under two years of age. These statements have not been evaluated by the Food & Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.